Cargando…
Epidermal growth factor‐containing fibulin‐like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B)
AIM: Epidermal growth factor‐containing fibulin‐like extracellular matrix protein 1(EFEMP1) has been found to be involved in the occurrence and development of many cancers. The relationship between EFEMP1 and the development of hepatocellular carcinoma (HCC) and the molecular mechanism are not fully...
Autores principales: | Hu, Jiangfeng, Duan, Bensong, Jiang, Weiliang, Fu, Sengwang, Gao, Hengjun, Lu, Lungen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558597/ https://www.ncbi.nlm.nih.gov/pubmed/30972979 http://dx.doi.org/10.1002/cam4.2144 |
Ejemplares similares
-
The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling
por: Roshini, Arivazhagan, et al.
Publicado: (2022) -
Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Acts as a Potential Diagnostic Biomarker for Prostate Cancer
por: Shen, Hao, et al.
Publicado: (2017) -
Expression of Semaphorin 3B (SEMA3B) in Various Grades of Endometrial Cancer
por: Dziobek, Konrad, et al.
Publicado: (2019) -
SEMA3B‐AS1 suppresses colorectal carcinoma progression by inhibiting Semaphorin 3B‐dependent VEGF signaling pathway activation
por: Wang, Yi‐Qing, et al.
Publicado: (2023) -
Dependency of Tamoxifen Sensitive and Resistant ER(+) Breast Cancer Cells on Semaphorin 3C (SEMA3C) for Growth
por: Bhasin, Satyam, et al.
Publicado: (2023)